FSG - Fåhraeus Startup and Growth

Investor type

VC

Founded

2021

AUM

-

Location

Lund, Skåne, Sweden

Investment Ticket

$1-5 m

Investment Stage

Series A Seed

Region of investment

Europe
Investor profile last updated: 08 October, 2026

Profile

FSG (Fåhraeus Startup and Growth) is a venture capital firm based in Lund, Sweden, that invests at the intersection of life science and technology: digital health, medtech, diagnostics and life science tools. It grew out of Fårö Capital, the family office that serial entrepreneur Christer Fåhraeus (founder of CellaVision, EQL Pharma and Anoto) set up in 2000, and was founded as a fund manager in 2021.

FSG invests €1–6M per company over time, often in tranches tied to milestones, mainly at Seed and Series A and selectively at Series B. It backs commercial-stage companies with early signs of product-market fit, with Scandinavia as its home base and investments across Europe. Its second fund, FSG Fund II, held its final close at SEK 848M in January 2025, with SEK 233M from the European Investment Fund and Saminvest as a cornerstone investor.

The portfolio counts 26 companies, among them Yazen, Oncorena, Fida Biosystems, Aplagon, OssDsign and IntuiCell. Fund II's first exit came in May 2026, when Roche acquired SAGA Diagnostics for up to $595M.

Industry

Biotechnology Medical Devices Life Sciences MedTech HealthTech

FSG - Fåhraeus Startup and Growth Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
FSG Fund II
Venture Capital (VC)
HealthTech
MedTech
Life Sciences
Medical Devices
Biotechnology
Seed
Series A
Europe
$1-5 m
$77 M
January 2025

Contacts

Name
Title
Email
avatar
Christer Fåhraeus General Partner
General Partner
c•••@•••
avatar
Linus Wiebe Managing General Partner
Managing General Partner
l•••@•••
Upgrade to see contacts
avatar
NJAY0tRiDdCBM48Q NJAY0tRiDdCBM48Q
NJAY0tRiDdCBM48Q
avatar
NJAY0tRiDdCBM48Q NJAY0tRiDdCBM48Q
NJAY0tRiDdCBM48Q
avatar
NJAY0tRiDdCBM48Q NJAY0tRiDdCBM48Q
NJAY0tRiDdCBM48Q
Investment-team contacts for FSG - Fåhraeus Startup and Growth — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about FSG - Fåhraeus Startup and Growth

FSG - Fåhraeus Startup and Growth is a venture capital firm. It backs companies at Series A and Seed, writing tickets of $1-5 m.
FSG - Fåhraeus Startup and Growth is located in Lund, Skåne, Sweden.
FSG - Fåhraeus Startup and Growth was founded in 2021.
FSG - Fåhraeus Startup and Growth invests in companies and startups in Biotechnology, Medical Devices, Life Sciences, MedTech, HealthTech.
FSG - Fåhraeus Startup and Growth invests in companies and startups in Europe.
FSG - Fåhraeus Startup and Growth invests in companies and startups at Series A, Seed.
FSG - Fåhraeus Startup and Growth usually invests $1-5 m on average.
FSG - Fåhraeus Startup and Growth can be reached through its website fsg.vc and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for FSG - Fåhraeus Startup and Growth — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query FSG - Fåhraeus Startup and Growth directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 08 October, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.